Gut microbiome and its clinical implications: exploring the key players in human health

Document Type

Article

Publication Date

10-1-2023

Publication Title

Current opinion in infectious diseases

Abstract

PURPOSE OF REVIEW: The human gut harbors a diverse community of microorganisms known as the gut microbiota. Extensive research in recent years has shed light on the profound influence of the gut microbiome on human health and disease. This review aims to explore the role of the gut microbiome in various clinical conditions and highlight the emerging therapeutic potential of targeting the gut microbiota for disease management.

RECENT FINDINGS: Knowledge of the influence of gut microbiota on human physiology led to the development of various therapeutic possibilities such as fecal microbiota transplant (FMT), phage therapy, prebiotics, and probiotics. Recently, the U.S. FDA approved two FMT products for the treatment of recurrent Clostridioides difficile infection with ongoing research for the treatment of various disease conditions.

SUMMARY: Advancement in the knowledge of the association between gut microbiota and various disease processes has paved the way for novel therapeutics.

Medical Subject Headings

Humans; Gastrointestinal Microbiome; Disease Management; Fecal Microbiota Transplantation; Phage Therapy; Probiotics

PubMed ID

37593952

ePublication

ePub ahead of print

Volume

36

Issue

5

First Page

353

Last Page

359

Share

COinS